Identification of a novel mutation in the arginine vasopressin-neurophysin II gene in familial central diabetes insipidus

Summary

Familial central diabetes insipidus is an inherited disease of predominant autosomal dominant trait characterized by a deficiency of arginine vasopressin. The arginine vasopressin-neurophysin II (AVP-NPII) gene consists of three exons and is located on chromosome 20p13 encoding for the precursor protein of AVP. We investigated two Caucasian families with a typical autosomal dominant trait of familial central diabetes insipidus, defined by deficiency of arginine vasopressin. After PCR amplification of exon 1 and exon 2/3, fragments were pooled and purified. Nucleotide sequencing was performed with the Taq DyeDeoxy-terminator cycle sequencing method using nested primers. Two mutations in the coding region of NPII were identified. In family C we found a heterozygous G ⇒ C missense mutation (AA61) in exon 2 leading to the substitution of cystein with serine. In family D a novel heterozygous nonsense mutation in exon 3 (AA 83, GAG ⇒ TAG) was indentified, leading to a stop codon instead of glutamine. Both mutations were confirmed by restriction analysis and were found in all affected but not in healthy family members or control subjects. We therefore have identified a missense mutation of the AVP-NPII gene and a novel mutation predicting a truncated protein.

Key words:

Central diabetes insipidus - AVP-neurophysin II gene

References

• 1 Abbes A P, Bruggeman B, Akker v. d. E LT, de Groot M R, Franken A AM, Drexhage V R, Engel H. Identification of two distinct mutations at the same nucleotide position, concomitantly with a novel polymorphism in the vasopressin-neurophysin II gene (AVP-NP II) in two dutch families with familial neurohypophysial diabetes insipidus.  Clin Chem. 2000;  46 1699-1703
• 2 Calvo B, Bilbao J R, Rodríguez A, Rodríguez-Arnao M D, Castaño K. Molecular analysis in familial neurohypophysial diabetes insipidus: early diagnosis of an asymptomatic carrier.  J Clin Endocrinol Metabol. 1999;  84 3351-3354
• 3 Calvo B, Bilbao J R, Urrutia I, Eizaguirre J, Gaztambide S, Castaño L. Identification of a novel nonsense mutation and missense substitution in the vasopressin-neurophysin II gene in two spanish kindred's with familial neurohypophysial diabetes insipidus.  J Clin Endocrinol Metab. 1997;  83 995-997
• 4 De Bree F M, Burbach J PH. Structure-function relationships of the vasopressin prohormone domains.  Cell Mol Neurobiol. 1998;  18 173-191
• 5 DiMeglio L A, Gagliardi P C, Browning J E, Quigley C A, Repaske D R. A missense mutation encoding Cys 67 → Gly in neurophysin II is associated with early onset autosomal dominant neurohypophyseal diabetes insipidus.  Mol Genet metab. 2001;  72 39-44
• 6 Fujii H, Iida S, Moriwaki K. Familial neurohypophyseal diabetes insipidus associated with a novel mutation in the vasopressin-neurophysin II gene.  Int J Mol Med. 2000;  5 229-234
• 7 Gagliardi P C, Bernasconji S, Repaske D R. Autosomal dominant neurohypophyseal diabetes insipidus associated with a missense mutation encoding Gly23 → Val in Neurophysin II.  J Clin Endocrinol Metab. 1997;  82 3643-3646
• 8 Grant F D, Ahmadi A, Hosley C M, Majzoub J A. Two novel mutations of the vasopressin gene associated with familial diabetes insipidus and identification of an asymptomatic carrier infant.  J Clin Endocrinol Metab. 1998;  83 3958-3964
• 9 Hansen L K, Rittig S, Robertson G L. Genetic basis of familial neurohypophyseal diabetes insipidus.  Trends Endocrinol Metab. 1997;  8 363-372
• 10 Heppner C, Kotzka J, Bullmann C, Krone W, Muller-Wieland D. Identification of mutations of the arginine vasopressin-neurophysin II gene in two kindred's with familial central diabetes insipidus.  J Clin Endocrinol Metab. 1998;  83 693-696
• 11 Ito M, Mori Y, Oiso Y, Saito H. A single base substitution in the coding region for neurophysin II associated with familial central diabetes insipidus.  J Clin Invest. 1991;  87 725-728
• 12 Ito M, Yu R N, Jameson L, Ito M. Mutant vasopressin precursors that cause autosomal dominant neurohypophyseal diabetes insipidus retain dimerization and impair the secretion of wild-type proteins.  J Biol Chem. 1999;  274 9029-9037
• 13 Nijenhuis M, Zalm R, Burbach J PH. A diabetes insipidus vasopressin prohormone altered outside central core of neurophysin accumulates in the endoplastmatic reticulum.  Mol Cell Endocrinol. 2000;  167 55-67
• 14 Longo N, Langley S D, Griffin L D, Elsas L J. Reduced mRNA and a nonsense mutation in the insulin-receptor gene produce heritable severe insulin resistance.  Am J Hum Genet. 1992;  50 998-1007
• 15 Rittig S, Robertson G L, Sigaard C, Kovacs L, Gregersen N, Nyborg J, Pedersen E B. Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindred's with familial autosomal dominant neurohypophysial diabetes insipidus.  Am J Hum Genet. 1996;  58 107-117
• 16 Rutishauser J, Kopp P, Gaskill M B, Kotlar T J, Roberton G R. A novel mutation (R97C) in the neurophysin moiety of prepro-vasopressin-neurophysin II associated with autosomal-dominant neurohypophyseal diabetes insipidus.  Mol Gen Metab. 1999;  67 89-92
• 17 Sauville E, Carney D, Battey J. The human vasopressin gene is linked to the oxytocin gene and is selectively expressed in a cultured lung cancer cell line.  J Biol Chem. 1985;  260 10,236-10,241
• 18 Scordis N, Tasalis P C, Hettinger J A, Kontou M, Herakleous E, Krishnamani M RS, Phillips J A. A novel arginine vasopressin-neurophysin II mutation causes autosomal dominant neurohypophyseal diabetes insipidus and morphologic pituitary changes.  Horm Res. 2000;  53 239-245
• 19 Siggard S, Rittig S, Corydon T J, Andreasen P H, Jensen T C, Andresen B S, Robertson G L, Gregersen N, Bollund L, Pedersen E B. Clinical and molecular evidence of abnormal processing and trafficking of the vasopressin preprohormone in a large kindred with familial neurohypophyseal diabetes insipidus due to a signal peptide mutation.  J Clin Endocrin Metab. 1999;  84 2933-2941
• 20 Willcutts M D, Felner E, White P C. Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin.  Human Molecular Genetics. 1999;  8 1303-1307